SWM
BNTX icon

SHP Wealth Management’s BioNTech BNTX Stock Holding History

SHP Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.78K Buy
110
+2
+2% +$206 ﹤0.01% 902
2025
Q4 		$10.3K Buy
+108
New +$10.9K ﹤0.01% 828

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SHP Wealth Management's BNTX Position: Q1 2026 in Review

SHP Wealth Management increased its BioNTech (BNTX) stake by 1.9% in Q1 2026, buying an estimated $206 and bringing the position to 110 shares worth $9.78K. The position accounts for ﹤0.01% of the portfolio, ranked #902.

SHP Wealth Management first reported a position in BNTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $10.3K in Q4 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • SHP Wealth Management held 110 shares of BioNTech worth $9.78K as of Q1 2026.
  • SHP Wealth Management bought 2 BioNTech shares in Q1 2026, an estimated $206.
  • BioNTech made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #902 holding.
  • SHP Wealth Management first reported a position in BioNTech in Q4 2025 and has held it in 2 quarters since.
  • SHP Wealth Management's BioNTech position peaked at $10.3K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.